M. E. Scheulen

7.2k citations
190 papers · 5.8k · 1 hit paper · h-index 38

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • Metal complexes synthesis and properties
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
  • Hematology top 2%

Papers in

    • Cancer Treatment and Pharmacology 32
    • Colorectal Cancer Treatments and Studies 16
    • Metal complexes synthesis and properties 10
    • Cancer therapeutics and mechanisms 16
    • Melanoma and MAPK Pathways 12

M. E. Scheulen

181 papers receiving 5.6k citations

M. E. Scheulen's Hit Papers

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors 2004 · 738 citations
7380+7+14Years since publication200400600

Peers

M. E. Scheulen
Comparison fields: 5 of 125
  • Oncology 2.3k
  • Hematology 497
  • Internal Medicine 144
  • Cancer Research 619
  • Hepatology 305
Replace Apurva A. Desai with:
Apurva A. Desai United States
Agop Y. Bedikian United States
Thomas H. Cartwright United States
Olivier Rixe France
Jean L. Grem United States
Dick J. Richel Netherlands
Daniel D. Karp United States
Neeltje Steeghs Netherlands
Claire F. Verschraegen United States
Roscoe F. Morton United States
M. E. Scheulen relative to Apurva A. Desai United States Apurva A. Desai's profile →
Citations per field
00.5×1.5×1.9×
Apurva A. Desai · 1×
Citations per year

Countries citing papers authored by M. E. Scheulen

Since Specialization
Citations

This map shows the geographic impact of M. E. Scheulen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Scheulen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Scheulen more than expected).

Fields of papers citing papers by M. E. Scheulen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. E. Scheulen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Scheulen. The network helps show where M. E. Scheulen may publish in the future.

Co-authors

The 25 scholars most cited alongside M. E. Scheulen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. E. Scheulen Line = papers co-authored together M. E. Scheulen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors
Hit paper breakdown →
2004738
2 2005408
3 2014277
4 2002219
5 2009215
6 2012211
7 2002177
8 2005164
9 2005150
10 2006124
11 2009109
12
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
1998105
13 2014104
14 2005104
15 2012102
16 200297
17
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
200092
18 200485
19 200785
20 201383

About M. E. Scheulen

M. E. Scheulen is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 190 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer therapeutics and mechanisms (16 papers), Testicular diseases and treatments (15 papers), Chemotherapy-induced cardiotoxicity and mitigation (13 papers), Melanoma and MAPK Pathways (12 papers), Ovarian cancer diagnosis and treatment (10 papers) and Metal complexes synthesis and properties (10 papers). The work is most often cited by research in Oncology (2.3k citations), Hematology (497 citations), Internal Medicine (144 citations), Cancer Research (619 citations) and Hepatology (305 citations). M. E. Scheulen has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dirk Strumberg, Ralf A. Hilger, S. Seeber, Heike Richly, H. Kappus, D. Voliotis, K. Mross, Brian Schwartz, E. Brendel and R. Voigtmann. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology, British Journal of Cancer, Cancer Treatment Reviews and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact